Dapagliflozin
SGLT2 inhibitor for diabetes, heart failure and kidney disease.
- Starts working
- Varies
- Half-life
- About 13 hours
- In use since
- 2012
- Pregnancy
- Usually avoided
Overview
Dapagliflozin was the first SGLT2 inhibitor approved. Big trials showed it reduces deaths and hospitalisations in heart failure and slows kidney disease, with or without diabetes.
Conditions it's used for
How it works
Pushes excess sugar and salt out through the urine.
Dapagliflozin belongs to the SGLT2 inhibitors. How SGLT2 inhibitors work: stop the kidneys reabsorbing glucose, so 60–80 g of sugar a day leaves in the urine. They also reduce fluid load and kidney pressure.
Uses
- Type 2 diabetes
- Heart failure (all ejection fractions)
- Chronic kidney disease
Available as: tablet, combination tablets.
Typical dose
- Adults
- 10 mg once a day.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Genital thrush
- Urinary infections
- Back pain
Serious — get medical help
Uncommon, but need prompt attention
- Ketoacidosis
- Dehydration
- Fournier's gangrene (rare)
Warnings
- Sick day rules: pause when unwell
- Stop 3 days before surgery
Who should avoid it
- Type 1 diabetes (risk of ketoacidosis)
- Severe dehydration or ongoing vomiting
- Recurrent genital or urinary infections
Interactions
- Insulin and sulfonylureas — hypos
- Loop diuretics — dehydration
Using it safely
- Alcohol
- Best to limit. Heavy drinking raises the risk of ketoacidosis.
- Food and drink
- With or without food.
- If you miss a dose
- Take it when you remember the same day; do not double up.
- Stopping it
- Hold during acute illness with vomiting, diarrhoea, fasting, or before surgery (per your doctor).
- Driving
- No effect when used alone.
- Tests and checks
- eGFR; HbA1c; Ketones if unwell
- If too much is taken
- Usually well tolerated; dehydration and ketoacidosis are risks. Seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Not recommended.
Breastfeeding
Usually avoided
Avoid.
Special groups
- Kidney disease
- Used for kidney and heart protection down to eGFR 15–25; less sugar-lowering.
- Liver disease
- No adjustment.
- Older adults
- Watch for dehydration and low blood pressure.
Brand names
- United States
- Farxiga
- United Kingdom
- Forxiga
- India
- Forxiga, Oxra, Udapa
- Australia
- Forxiga
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
History
2019
DAPA-HF: fewer deaths in heart failure, with or without diabetes.
2020
DAPA-CKD stopped early for clear kidney benefit.
Common questions
Does it work if I don't have diabetes?
Yes, for heart failure and kidney disease the benefits are similar with or without diabetes.
Do I need a prescription for Dapagliflozin?
Yes — Dapagliflozin is prescription-only in most countries.
Can I take Dapagliflozin during pregnancy?
Usually avoided. Not recommended. Always check with a doctor or midwife.
Related medicines
Empagliflozin
Diabetes tablet that also protects heart and kidneys.
RxSGLT2 inhibitorsMetformin
First-choice tablet for type 2 diabetes.
RxWHOBiguanidesCanagliflozin
Diabetes tablet that makes the kidneys pass out extra sugar.
RxSGLT2 inhibitorsSitagliptin
Gentle once-daily diabetes tablet with low hypo risk.
RxDPP-4 inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — A10BK01
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.